Abstract:Developmental toxicology is a constantly evolving research field which needs to attend to a complex underlying regulatory network. In order to ensure human health and environmental safety, new substances have to be tested for toxic effects on reproduction and development, before being commercialized. Traditional in vivo mammalian models represent the intricacy of human development and provide more adequately an assessment of the interaction of chemical compounds with the reproductive system. However, in the last years, the directives are to reduce the use of vertebrate animals, promoting their use only as a last resort. Consequently, the interest on the development and validation of alternative tests, able to cover the various aspects of the reproductive cycle, has significantly increased. Reproductive toxicity is probably the most difficult endpoint to be replaced by alternative assays, since it should provide information on mechanism interactions essential for female and male fertility and also knowledge on the animal development during the first phases of its life cycle. This complexity explains the slow progress in implementing alternative models for reproductive toxicity safety assays. Alternative test models may be based on in vitro systems and nonmammalian animal models. Many biological processes have been successfully addressed using in vitro models, opening the possibility to study the interference of teratogenic compounds. Their validation and implementation have lagged behind, in part because of difficulties in establishing their predictability. Nevertheless, the advance toward the process of validation is crucial to replace and reduce the use of living animals. Based on the present state of the art, it is not probable that such testing strategies will completely replace the need to assess reproductive toxicity in vivo in the near future, but they will contribute to reduce animal tests and will provide important information. In this chapter, the approved guidelines for standard methods and alternative methods, according to their regulatory and scientific status, are enumerated and briefly described.

25th anniversary of the Berlin workshop on developmental toxicology: DevTox database update, challenges in risk assessment of developmental neurotoxicity and alternative methodologies in bone development and growth.

Update of the DevTox Data Database for Harmonized Risk Assessment and Alternative Methodologies in Developmental Toxicology: Report of the 9th Berlin Workshop on Developmental Toxicity.

Continuing Harmonization of Terminology and Innovations for Methodologies in Developmental Toxicology: Report of the 8th Berlin Workshop on Developmental Toxicity, 14–16 May 2014

Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing

New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project

Consensus report on the future of animal-free systemic toxicity testing

New approach methodologies in human regulatory toxicology - Not if, but how and when!

Examining animal testing for risk assessment: A WC-12 workshop report

The Precision Toxicology initiative

Guidelines on Developmental Toxicity Tests: Brief Insights

Progress in Alternatives for Developmental Neurotoxicity Testing on Animals

New approaches for assessing the etiology and risks of developmental abnormalities from chemical exposure

Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

New approach methodologies to confirm developmental toxicity of pharmaceuticals based on weight of evidence

A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals

The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods

A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures

Current Knowledge, Challenges and Innovations in Developmental Pharmacology: A Combined Conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper

A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity

In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities

Interlaboratory validation of the ToxTracker assay: An in vitro reporter assay for mechanistic genotoxicity assessment